Relative amount of patients with surgery, non-surgical treatment and complications from baseline to 25 months later.

A: Percentage of patients undergoing scheduled surgical vs. non-surgical BVFP treatment and of patients requiring no BVFP-related treatment from the baseline to the last follow-up visit (max. 25 months after baseline). B: Evaluation of the changes in the BVFP symptomology and need of symptom medical treatment from the baseline to the last follow-up visit. C: Changes in the detection of BVFP- vs. BVFP treatment-related complications from the baseline to the last follow-up visit. The percentage of patients was always calculated on the total number of patients for which medical acts were available at the respective check-point.